Our findings demonstrate a modest but significant improvement in DSS for those diagnosed with metastasis of ATC, FTC (borderline significance), MTC, and OTC in the most recent decade (2012–2022) compared to earlier periods.
← all excerpts
Trends in metastatic thyroid cancer survival from 1992 to 2022: a SEER database analysis.
1
—
—